Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Nebivolol and Valsartan in Hypertension
NCT01415505Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Aug 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol, valsartan in hypertension (HTN), sponsored by Forest Laboratories. Started Aug 2011; status: completed.
02
Drugs
nebivololvalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01415505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415505.